Paper16635002
Mesenchymal stem cells and bone regeneration.
Kraus KH and 1 other. Vet Surg, 2006. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Mesenchymal stem cells and bone regeneration. Papers, record 16635002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16635002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fracture Healing | Major topic |
| Fractures, Bone | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Animals | |
| Bone Regeneration | |
| Dogs |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930840 | Regenerative Biomaterials and Emerging Biological Strategies for Peri-Implantitis: Current Clinical Evidence from a Structured Narrative Review. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42930840 | PubMed |
| 42272959 | SHEDs and BMSCs exhibit distinct lineage preferences in HUVECs dynamic spheroid co-cultures: vascular versus osteogenic commitment. | Bioeng Transl Med | 2026 | https://conductscience.org/library/papers/42272959 | PubMed |
| 41852880 | Hyaluronan open-pit nanofibrils with spontaneous cell-matrix assembly for advanced osteochondral defect repair. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41852880 | PubMed |
| 41124397 | The comparison of the applicability of low-frequency laser, β-tricalcium phosphate, platelet-rich fibrin, and bone marrow in the treatment of tibial fractures in rabbits. | Acta Cir Bras | 2025 | https://conductscience.org/library/papers/41124397 | PubMed |
| 39729188 | The use of autologous chondrocyte transplantation for the treatment of osteoarthritis: a systematic review of clinical trials. | Cell Tissue Bank | 2024 | https://conductscience.org/library/papers/39729188 | PubMed |
| 38136656 | Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells. | Biomolecules | 2023 | https://conductscience.org/library/papers/38136656 | PubMed |
| 37982124 | Successful treatment of a benign, non-infected cyst in a dog by bone marrow injections. | Vet Med (Praha) | 2023 | https://conductscience.org/library/papers/37982124 | PubMed |
| 34948393 | Three-Dimensional Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Promotes Matrix Metallopeptidase 13 (MMP13) Expression in Type I Collagen Hydrogels. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948393 | PubMed |
| 34648374 | Modern approaches on stem cells and scaffolding technology for osteogenic differentiation and regeneration. | Exp Biol Med (Maywood) | 2022 | https://conductscience.org/library/papers/34648374 | PubMed |
| 34420103 | Repair of long bone defects of large size using a tissue-engineered periosteum in a rabbit model. | J Mater Sci Mater Med | 2021 | https://conductscience.org/library/papers/34420103 | PubMed |
| 34124233 | Safety and therapeutic potential of human bone marrow-derived mesenchymal stromal cells in regenerative medicine. | Stem Cell Investig | 2021 | https://conductscience.org/library/papers/34124233 | PubMed |
| 34095630 | Fullerol-hydrogel microfluidic spheres for in situ redox regulation of stem cell fate and refractory bone healing. | Bioact Mater | 2021 | https://conductscience.org/library/papers/34095630 | PubMed |
| 32915522 | Regeneration enhanced in critical-sized bone defects using bone-specific extracellular matrix protein. | J Biomed Mater Res B Appl Biomater | 2021 | https://conductscience.org/library/papers/32915522 | PubMed |
| 32911737 | A New Polycaprolactone-Based Biomembrane Functionalized with BMP-2 and Stem Cells Improves Maxillary Bone Regeneration. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/32911737 | PubMed |
| 31784696 | 3D Titania Nanofiber-Like Webs Induced by Plasma Ionization: A New Direction for Bioreactivity and Osteoinductivity Enhancement of Biomaterials. | Sci Rep | 2019 | https://conductscience.org/library/papers/31784696 | PubMed |
| 31687506 | Simvastatin enhances proliferation and pluripotent gene expression by canine bone marrow-derived mesenchymal stem cells (cBM-MSCs) in vitro. | Heliyon | 2019 | https://conductscience.org/library/papers/31687506 | PubMed |
| 31616536 | Suitability and limitations of mesenchymal stem cells to elucidate human bone illness. | World J Stem Cells | 2019 | https://conductscience.org/library/papers/31616536 | PubMed |
| 31331380 | Effect of SDF-1 with biphasic ceramic-like bone graft on the repair of rabbit radial defect. | J Orthop Surg Res | 2019 | https://conductscience.org/library/papers/31331380 | PubMed |
| 30813284 | Calcium Phosphate Spacers for the Local Delivery of Sitafloxacin and Rifampin to Treat Orthopedic Infections: Efficacy and Proof of Concept in a Mouse Model of Single-Stage Revision of Device-Associated Osteomyelitis. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/30813284 | PubMed |
| 30498742 | Equine bone marrow-derived mesenchymal stem cells: optimization of cell density in primary culture. | Stem Cell Investig | 2018 | https://conductscience.org/library/papers/30498742 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16635002
GET https://conductscience.org/api/papers/v1/16635002/cited_by?page=2